Analytical Data
-
基因名
PTGR2
- Application
-
别名
PTGR2;ZADH1;Prostaglandin reductase 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N8N7
-
表达区间
1-351aa
-
氨基酸序列
MGSSHHHHHH SSGLVPRGSH MGSHMIVQRV VLNSRPGKNG NPVAENFRME EVYLPDNINE GQVQVRTLYL SVDPYMRCRM NEDTGTDYIT PWQLSQVVDG GGIGIIEESK HTNLTKGDFV TSFYWPWQTK VILDGNSLEK VDPQLVDGHL SYFLGAIGMP GLTSLIGIQE KGHITAGSNK TMVVSGAAGA CGSVAGQIGH FLGCSRVVGI CGTHEKCILL TSELGFDAAI NYKKDNVAEQ LRESCPAGVD VYFDNVGGNI SDTVISQMNE NSHIILCGQI SQYNKDVPYP PPLSPAIEAI QKERNITRER FLVLNYKDKF EPGILQLSQW FKEGKLKIKE TVINGLENMG AAFQSMMTGG NIGKQIVCIS EEISL
-
分子量
41 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PTGR2, or Prostaglandin-Tyrosine-Protein Kinase Receptor 2, is a crucial enzyme implicated in the metabolic pathways of prostaglandins, which are bioactive lipids that play a significant role in various physiological processes, including inflammation, pain, and regulation of vascular functions. Recent studies have highlighted the importance of PTGR2 in the pathophysiology of several diseases, including cancer, cardiovascular disorders, and metabolic syndromes. As researchers continue to explore the intricate mechanisms underlying these diseases, PTGR2 has emerged as a potential therapeutic target. The recombinant expression of PTGR2 provides an avenue for elucidating its structural and functional properties. By studying the recombinant protein, scientists aim to better understand its enzymatic activity, interaction with substrates, and modulation by other cellular factors. This knowledge can lay the groundwork for the development of novel inhibitors or activators that can be used in drug design, potentially leading to more effective treatment strategies. Furthermore, the production of recombinant PTGR2 can facilitate high-throughput screening of compounds that impact its activity, thus accelerating drug discovery processes. Therefore, the investigation of PTGR2 as a recombinant protein holds promise not only for advancing our understanding of its biological roles but also for contributing to the development of new therapeutic interventions in various disease contexts.
